Overview

GU-01: Glycyrrhizin in Prostate Cancer

Status:
RECRUITING

Trial end date:
2026-03-01

Target enrollment:

Participant gender:

Summary

This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)

Phase:

PHASE2

Details

Lead Sponsor:

University of Illinois at Chicago

Treatments:

Glycyrrhizic Acid
Observation